Skip to Content

WARRICK 1670 (Theophylline Extended-Release 300 mg)

Pill with imprint WARRICK 1670 is White, Capsule-shape and has been identified as Theophylline Extended-Release 300 mg. It is supplied by Warrick Pharmaceuticals Corporation.

Theophylline is used in the treatment of asthma, maintenance; asthma, acute; apnea of prematurity and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WARRICK 1670

Theophylline Extended-Release

Imprint
WARRICK 1670
Strength
300 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Methylxanthines
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Warrick Pharmaceuticals Corporation
National Drug Code (NDC)
59930-1670

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.